NO870577L - UNSATURED AMINO ACIDS. - Google Patents

UNSATURED AMINO ACIDS.

Info

Publication number
NO870577L
NO870577L NO870577A NO870577A NO870577L NO 870577 L NO870577 L NO 870577L NO 870577 A NO870577 A NO 870577A NO 870577 A NO870577 A NO 870577A NO 870577 L NO870577 L NO 870577L
Authority
NO
Norway
Prior art keywords
alkyl
amino
hydroxy
phosphono
pentenoic acid
Prior art date
Application number
NO870577A
Other languages
Norwegian (no)
Other versions
NO870577D0 (en
NO170938C (en
NO170938B (en
Inventor
Christof Angst
Derek Edward Brundisch
John Grey Dingwall
Graham Eric Fagg
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO870577D0 publication Critical patent/NO870577D0/en
Publication of NO870577L publication Critical patent/NO870577L/en
Publication of NO170938B publication Critical patent/NO170938B/en
Publication of NO170938C publication Critical patent/NO170938C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/3804Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se) not used, see subgroups
    • C07F9/3826Acyclic unsaturated acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/30Phosphinic acids R2P(=O)(OH); Thiophosphinic acids, i.e. R2P(=X)(XH) (X = S, Se)
    • C07F9/302Acyclic unsaturated acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/30Phosphinic acids R2P(=O)(OH); Thiophosphinic acids, i.e. R2P(=X)(XH) (X = S, Se)
    • C07F9/32Esters thereof
    • C07F9/3205Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/3217Esters of acyclic unsaturated acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4015Esters of acyclic unsaturated acids

Abstract

Phosphorus-contg. unsaturated amino acids of formula (I) and their salts are new: R1 = hydroxy or etherified hydroxy; R2 = H, alkyl, hydroxy or etherified hydroxy; R3 = H, alkyl, haloalkyl, hydroxyalkyl, lower alkoxyalkyl, arylalkyl, lower alkenyl, halogen or aryl; R4 = H, alkyl or arl; R5 = H or alkyl; R6 = carboxy or esterified or amidated carboxy; R7 0 amino opt. substd. by alkyl or aryl; A = opt. alkyl-substd. 1-3C alpha, omega-alkylene or a direct bond; B = methyleue or direct bond; provided that A and B are both direct bonds. Specifically claimed are 9 cpds. including E-2-amino-5- phosphono-3-pentenoic acid, E-2-amino-4-methyl-5-phosphono -3-pentenoic acid, and E-2-amino-4-methyl -5-phosphono-3-pentenoic acid ethyl ester.
NO870577A 1986-02-13 1987-02-13 ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY EFFECTIVE PHOSPHONOSUBSTITUTED AMINOALKY ACIDS NO170938C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH57886 1986-02-13

Publications (4)

Publication Number Publication Date
NO870577D0 NO870577D0 (en) 1987-02-13
NO870577L true NO870577L (en) 1987-08-14
NO170938B NO170938B (en) 1992-09-21
NO170938C NO170938C (en) 1992-12-30

Family

ID=4190244

Family Applications (1)

Application Number Title Priority Date Filing Date
NO870577A NO170938C (en) 1986-02-13 1987-02-13 ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY EFFECTIVE PHOSPHONOSUBSTITUTED AMINOALKY ACIDS

Country Status (23)

Country Link
EP (1) EP0233154B1 (en)
JP (2) JPH0717665B2 (en)
KR (1) KR900003533B1 (en)
AT (1) ATE70535T1 (en)
AU (1) AU610493B2 (en)
CA (1) CA1331625C (en)
CY (1) CY1821A (en)
DD (1) DD263775A5 (en)
DE (1) DE3775229D1 (en)
DK (1) DK169341B1 (en)
ES (1) ES2038690T3 (en)
FI (1) FI85144C (en)
GR (1) GR3003526T3 (en)
HK (1) HK95594A (en)
HU (1) HU204532B (en)
IE (1) IE59417B1 (en)
IL (1) IL81543A0 (en)
NO (1) NO170938C (en)
NZ (1) NZ219255A (en)
PH (1) PH23762A (en)
PT (1) PT84270B (en)
SG (1) SG92294G (en)
ZA (1) ZA871022B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175344A (en) * 1986-02-13 1992-12-29 Ciba-Geigy Corporation Unsaturated amino acids
EP0263502A3 (en) * 1986-10-09 1990-05-02 Ciba-Geigy Ag Oligopeptide antibiotics
PH27591A (en) * 1987-08-04 1993-08-31 Ciba Geigy Ag A process for the manufacture of novel unsaturated amino acid compound
US5175153A (en) * 1987-11-30 1992-12-29 Warner-Lambert Company Substituted alpha-amino acids having pharmaceutical activity
US5179085A (en) * 1989-03-15 1993-01-12 Warner-Lambert Company N-substituted α-amino acids and derivatives thereof having pharmaceutical activity
ES2060122T3 (en) * 1989-04-07 1994-11-16 Ciba Geigy Ag UNSATURATED DERIVATIVES OF AMINODICARBOXILIC ACIDS.
US5500419A (en) * 1989-09-19 1996-03-19 Merrell Dow Pharmaceuticals Inc. NMDA antagonists
US5488140A (en) * 1989-09-26 1996-01-30 Ciba-Geigy Corporation 4-substituted 2-aminoalk-3-enoic
US5294734A (en) * 1989-09-26 1994-03-15 Ciba-Geigy Corp. 4-substituted 2-aminoalk-3-enoic acids
ATE124700T1 (en) * 1989-09-26 1995-07-15 Ciba Geigy Ag PHOSPHONIC ACID, METHOD FOR PRODUCTION AND USE AS A MEDICINAL ACTIVE INGREDIENT.
US5238958A (en) * 1990-02-26 1993-08-24 Warner-Lambert Company Substituted α-amino acids having selected acidic moieties for use as excitatory amino acid antagonists in pharmaceuticals
JPH07505908A (en) * 1992-09-28 1995-06-29 マックセチーニ、マリア ルイザ Allosteric modulator of NMDA receptor
US20090170813A1 (en) * 2005-10-18 2009-07-02 Francine Acher Hypophosphorous Acid Derivatives and their Therapeutical Applications
DE102007032669A1 (en) 2007-07-13 2009-01-15 Clariant International Limited Alkylphosphonous acids, salts and esters, process for their preparation and their use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5387314A (en) * 1977-01-07 1978-08-01 Heiichi Sakai Nn14099substance
US4477391A (en) * 1981-08-14 1984-10-16 Collins James F Amino acid isomers, their production and their medicinal use
GB2104079B (en) * 1981-08-14 1985-08-21 London Polytech New aminoacid isomers, their production and their medicinal use

Also Published As

Publication number Publication date
IL81543A0 (en) 1987-09-16
JPH07206683A (en) 1995-08-08
FI870558A (en) 1987-08-14
FI870558A0 (en) 1987-02-11
JPS62246586A (en) 1987-10-27
CY1821A (en) 1995-10-20
DK70787A (en) 1987-08-14
KR900003533B1 (en) 1990-05-21
DD263775A5 (en) 1989-01-11
HU204532B (en) 1992-01-28
AU610493B2 (en) 1991-05-23
DK70787D0 (en) 1987-02-12
PT84270A (en) 1987-03-01
EP0233154A2 (en) 1987-08-19
NO870577D0 (en) 1987-02-13
CA1331625C (en) 1994-08-23
GR3003526T3 (en) 1993-03-16
ZA871022B (en) 1987-09-30
PT84270B (en) 1989-09-14
PH23762A (en) 1989-11-03
EP0233154A3 (en) 1989-06-14
ATE70535T1 (en) 1992-01-15
HK95594A (en) 1994-09-16
NO170938C (en) 1992-12-30
JP2509465B2 (en) 1996-06-19
NZ219255A (en) 1989-08-29
FI85144C (en) 1992-03-10
KR870007942A (en) 1987-09-23
EP0233154B1 (en) 1991-12-18
JPH0717665B2 (en) 1995-03-01
NO170938B (en) 1992-09-21
ES2038690T3 (en) 1993-08-01
AU6872687A (en) 1987-08-20
IE870365L (en) 1987-08-13
SG92294G (en) 1995-04-28
FI85144B (en) 1991-11-29
IE59417B1 (en) 1994-02-23
DE3775229D1 (en) 1992-01-30
DK169341B1 (en) 1994-10-10
HUT43863A (en) 1987-12-28

Similar Documents

Publication Publication Date Title
NO870577L (en) UNSATURED AMINO ACIDS.
EE03999B1 (en) Use of fumaric acid derivatives
NO932614L (en) Heterosexual Acetic Acid Derivatives
ES414279A1 (en) Benzodiazepine derivatives
ES2057126T3 (en) TREATMENT METHOD OF CAQUEXIA AND SOME NEW COMPOUNDS TO USE IN THIS METHOD.
ES2058173T3 (en) DIOXIALQUILENARIL-DIHIDROPIRIDINAS, INTERMEDIATE PRODUCTS FOR ITS MANUFACTURE, PROCEDURES FOR ITS MANUFACTURE AND ITS USE.
FI971711A (en) Crystallization of levobupivacaine and its analogues
DK0552060T3 (en) Imidazole derivatives with anti-HIV effect
ATE32715T1 (en) PROCESS FOR THE PREPARATION OF B-((2METHYLPROPOXY)-METHYL>-N-PHENYL-N-(PHENYLMETHYL - 1-PYRROLIDINETHANAMINE.
GB1369577A (en) Indole-carboxylic acid derivatives
NO870077D0 (en) NEW TYRONINE DERIVATIVES.
ATE114153T1 (en) 3,6-DIAMINO-2,5-PYRAZINEDICARBONITRILE AND ITS PRODUCTION.
ES2038260T3 (en) PROCEDURE FOR THE PREPARATION OF DERIVATIVES OF PHENOXIALKYLCARBOXYLIC ACID.
FR2278326A1 (en) 2'-Aminoethyl 3,5'-dimethyl (thio)benzoates - as anti-ulcerogenic agents
ES476031A1 (en) Maleic acid halfamides having blood pressure raising activity
FR2070103A1 (en) Antiphlogistic 1- (hydroxy amido or amino) - acenaphthenes
NL6906967A (en) Phthalimidine derivs tumour-inhibiting etc
FR2244489A1 (en) 3-Halo-4-heterocyclic substd.-phenylalkanoic acids - their esters and salts with antiinflammatory activity
FR2442052A1 (en) Human glaucoma treatment with labetalol - which is an amino- and hydroxyalkyl substd. salicylamide
PT80187A (en) A process for the preparation of quinoline carboxylic acid derivatives
HUP0000414A2 (en) New pentaerythritol derivatives,their production and use and intermediates for their synthesis
HUT40100A (en) Process for producing quinolin-carboxylic acid derivatives
IT1047895B (en) 1,3-benzodioxol-2-yl alkanoic acid and amide derivs - -antiinflammatories, analgesics, antipyretics, antitussives, cns-depr